Developer docs
API playgroundTry for free, no card

Search company profiles

Laborie Medical Technologies

Full company profile

uuid0004wmv

Namestring
Laborie Medical Technologies
Legal namestring
Laborie Medical Technologies Corp.
Websiteurl
laborie.com
Company typeenum
Private
Founded yearint
1976
Descriptiontext

Laborie Medical Technologies is a privately held, Portsmouth, New Hampshire-headquartered global medical device company that develops, manufactures, and markets diagnostic and therapeutic products across three specialty franchises: Urology & Urogynecology, Gastroenterology, and Maternal & Child Health. Founded in 1967 (per firmographic data) and operating with 501-1,000 employees, the company sells capital equipment systems such as the NXT, Aquarius, and Goby urodynamics platforms, the alpHaONE wireless pH capsule for GERD, and the Solar high-resolution manometry system for GI diagnostics, alongside therapeutic devices including the Optilume drug-coated balloon for BPH and urethral stricture, the Eclipse vaginal insert for fecal incontinence, the JADA vacuum-induced system for postpartum hemorrhage, and the LifeBubble umbilical catheter securement device for NICU use. Revenue is generated through hardware sales of capital equipment and recurring consumables (catheters, sensors, balloons, single-use accessories) sold via a direct enterprise sales force and a global distributor network of 100+ partners across more than 50 countries, supplemented by CME-accredited professional education services delivered through partnerships including the International Continence Society.

Laborie's growth model is built on a programmatic acquisition strategy executed since the 2012 Audax Private Equity investment, with notable transactions including Clinical Innovations (2019, $525M), Cogentix Medical (2018, $239M), Pelvalon (2021), GI Supply (2022), Novonate (2023), Urotronic (2023, ~$600M), and the announced JADA System acquisition from Organon (2025, up to $465M), which together have built a multi-specialty medical device platform with installed bases in over 2,000 U.S. hospitals and 20+ countries for flagship products. The company differentiates through FDA-cleared novel mechanism devices supported by peer-reviewed clinical data (including five-year Optilume efficacy publications and an 86.4% Eclipse success rate at three months), Category 1 CPT reimbursement codes for Optilume BPH, and a global regulatory footprint spanning FDA, CE, and TGA approvals across major geographies.

Go-to-market combines direct enterprise field sales targeting hospital systems and specialist physician practices in urology, urogynecology, gastroenterology, and obstetrics with a tiered regional structure of owned subsidiary offices in the US, Netherlands, UK, France, Germany, Canada, Australia, and China, complemented by extensive distributor relationships across Europe, Asia, the Middle East, Africa, Latin America, and Oceania. Marketing emphasizes clinical evidence and physician education through live courses, webinars, expert corner content, and an e-learning partnership with the International Continence Society, while a Find a Provider directory supports patient access to Laborie-treated providers.

Short descriptiontext

Laborie Medical Technologies is a privately held global medical device company that develops and sells diagnostic and therapeutic products for urology, urogynecology, gastroenterology, and maternal and child health, serving hospitals, specialty practices, and health systems in over 50 countries via direct sales and distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersPortsmouth, United States
HQ citystring
Portsmouth
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic medical devices, urodynamics systems, maternal health devices, gastroenterology equipment, urology therapeutics
Industry3 codes
1Compression Therapy & Lymphedema DME (Garments, Pneumatic Pumps)
CodeHLAHAMAHPrimaryYes
2Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers)
CodeHLAHAGAKPrimaryNo
3Healthcare & Hospital Linen Laundry
CodeHSAJAEAAPrimaryNo
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Devices (Diagnostic and Therapeutic)
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of diagnostic equipment, therapeutic devices, and capital equipment to hospitals and healthcare providers. Includes urodynamics systems, bladder scanners, drug-coated balloons, and surgical devices.

laborie.com
2Consumables and Accessories
TypeHardware Sales
Description

Recurring revenue from catheters, sensors, balloons, and other single-use consumables used with diagnostic and treatment systems.

laborie.com
3Professional Services and Training
TypeProfessional Services
Description

Education services including live courses, online courses, webinars, and training programs for healthcare professionals on product usage and clinical procedures.

laborie.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise/B2B medical device sales - quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Medical devices sold through healthcare system procurement processes with custom quotations based on volume, configuration, and contract terms

laborie.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Medical Measurement Systems
Description

European headquarters and medical measurement systems subsidiary

laborie.com
+1 more record
Core offering1 text field

Laborie Medical Technologies is a global developer, manufacturer, and marketer of proprietary diagnostic and therapeutic medical devices for urology, urogynecology, gastroenterology, and maternal/child health. The company sells capital equipment (urodynamics systems, high-resolution manometry, pH monitoring), therapeutic devices (drug-coated balloons, postpartum hemorrhage control, neuromodulation), and recurring consumables (catheters, sensors, balloons) to hospitals and specialty clinics in 50+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 86.4% success rate at 3 months for Eclipse System in pivotal study
+2 more records
Product overview1 text field

Laborie Medical Technologies operates as a global medical technology company organized around three core specialty areas: Urology & Urogynecology, Gastroenterology, and Maternal & Child Health. The company offers diagnostic and therapeutic medical devices across these domains, with products ranging from advanced urodynamics systems (NXT™, Aquarius®, Goby, Nexam Pro) and drug-coated balloon technologies (Optilume® for BPH and urethral stricture) to gastrointestinal diagnostics (alpHaONE, Solar™ systems, Ohmega™) and maternal-neonatal solutions (JADA® System, LifeBubble®, Kiwi®, Koala®, ABBy™). The portfolio includes both capital equipment systems and disposable consumables, with some products acquired through strategic acquisitions such as Pelvalon (Eclipse™ System), Novonate (LifeBubble®), GI Supply, and Urotronic (Optilume® drug-coated balloon technology).

Product and service25 records
1NXT™ Family of Urodynamics Systems
CategoryUrodynamics Diagnostics
Description

Advanced urodynamics diagnostic system for evaluating bladder and urethral function in urology and urogynecology patients, used by hospital urology departments and specialty practices.

2Optilume® BPH Catheter System
CategoryUrology Therapeutics
Description

Drug-coated balloon catheter system with paclitaxel coating for treatment of Benign Prostatic Hyperplasia (BPH), offering a minimally invasive alternative to traditional surgery. FDA-cleared with AMA Category 1 CPT code.

3Optilume® Urethral Drug Coated Balloon
CategoryUrology Therapeutics
Description

Drug-coated balloon technology for treatment of anterior urethral stricture, mechanically opening the urethra while delivering anti-proliferative paclitaxel medication for durable patency.

4JADA® System
CategoryObstetrics / Postpartum Care
Description

FDA-cleared vacuum-induced device for rapid control of abnormal postpartum uterine bleeding, used in hospital labor and delivery units. Available in 2,000+ US hospitals and 20+ countries.

5alpHaONE Wireless pH Capsule Reflux Monitoring System
CategoryGastroenterology Diagnostics
Description

Wireless capsule-based pH monitoring system for gastroesophageal reflux disease (GERD) diagnosis, enabling prolonged esophageal pH monitoring without catheter discomfort.

6Eclipse™ System
CategoryPelvic Floor Therapeutics
Description

FDA-cleared vaginal insert for non-surgical treatment of fecal incontinence in women, offering a middle-ground treatment option between conservative care and invasive surgery. Pivotal study showed 86.4% success rate at 3 months.

7LifeBubble® Umbilical Catheter Securement System
CategoryNeonatal Intensive Care
Description

NICU medical device for securement of umbilical catheters in neonates, improving safety and outcomes for newborns in intensive care.

8Aquarius® Family of Urodynamics Systems
CategoryUrodynamics Diagnostics
Description

Comprehensive urodynamics testing platform for assessment of lower urinary tract function, used in urology and urogynecology practices.

9Goby Family of Wireless Urodynamics Systems
CategoryUrodynamics Diagnostics
Description

Wireless Bluetooth-enabled urodynamics system offering cable-free diagnostic testing for enhanced patient comfort and workflow efficiency.

10Portascan™ 3D Ultrasound Bladder Scanner
CategoryUrology Diagnostics
Description

3D ultrasound imaging device for non-invasive bladder volume measurement and assessment.

11Macroplastique®
CategoryUrology Therapeutics
Description

Minimally invasive injectable bulking agent for treatment of stress urinary incontinence in adult women, primarily due to intrinsic sphincter deficiency.

12URGENT® PC
CategoryNeuromodulation Therapy
Description

Percutaneous tibial nerve stimulation (PTNS) system for treatment of overactive bladder and fecal incontinence, providing non-surgical neuromodulation therapy.

13Solar™ GI High-Resolution Manometry
CategoryGastroenterology Diagnostics
Description

High-resolution manometry system for comprehensive gastrointestinal diagnostic assessment of esophageal and anorectal function.

14Kiwi® Complete Vacuum Delivery System
CategoryObstetrics / Delivery
Description

Vacuum-assisted delivery system for obstetrics, designed to facilitate safe childbirth when intervention is required.

15ABBy™ Postoperative Panniculus Retractor
CategoryObstetric / Gynecologic Surgery
Description

Surgical retractor device for postoperative panniculus management, supporting wound care and recovery.

16Koala® Intrauterine Pressure Catheter
CategoryObstetrics / Labor Monitoring
Description

Intrauterine pressure monitoring catheter for labor management, providing accurate contraction measurement during childbirth.

17Ohmega™
CategoryGastroenterology Diagnostics
Description

Impedance/pH monitoring system for comprehensive diagnosis of gastroesophageal reflux disease.

18PrimeSight® Flexible Cystoscope
CategoryUrology Endoscopy
Description

Flexible video cystoscope with disposable endosheath technology for urological examination, enabling reusable scope functionality with single-use sheath.

19Spot® Ex Endoscopic Tattoo
CategoryGastroenterology Therapeutics
Description

Endoscopic tattoo marking system for colonic lesion localization during laparoscopic surgery.

20BabyLance™ Safety Heelstick
CategoryNeonatal Care
Description

Safety lancet device designed for safe and effective heel stick blood sampling in neonates.

21Nexam Pro Urodynamics System
CategoryUrodynamics Diagnostics
Description

Advanced urodynamics diagnostic platform for comprehensive bladder function assessment.

22Sonesta Chair Range
CategoryUrology / Gynecology Procedural Furniture
Description

Specialized examination chair designed for urology and gynecology procedures, offering optimized patient positioning and clinician accessibility.

23ROM Plus® Rupture of Membrane Test
CategoryObstetric Diagnostics
Description

Rapid diagnostic test for detection of rupture of fetal membranes during pregnancy assessment.

24Renova® Products
CategoryGastroenterology Therapeutics
Description

Centesis system for therapeutic fluid drainage procedures in gastroenterology.

25Solar™ Compact System
CategoryGastroenterology Diagnostics
Description

Compact high-resolution manometry system for gastrointestinal diagnostics, providing detailed pressure mapping of the digestive tract.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2026-05-18
Description

Laborie sponsors the AUA Early-Stage Innovation Nexus Award, a $20,000 grant recognizing exceptional early-stage startups in urology. This partnership supports Laborie's commitment to investing in innovation to advance urologic care.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Laborie partnered with ICS in developing new Urodynamic modules as part of its eLearning portfolio. The CME-accredited ICS eLearning courses provide comprehensive education from leading experts in Urodynamics.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Coloplast is a direct peer with overlapping portfolios in urology (BPH, urinary continence) and ostomy care, including the Alfapump and BPH device franchises. Both companies serve the same urology specialty customer base with diagnostic and therapeutic solutions.

TypeBroad incumbent
Description

Boston Scientific is a broad medtech incumbent with a significant urology and pelvic health franchise (including its recent Axonics acquisition) that overlaps directly with Laborie's urodynamics, BPH, and incontinence product lines.

TypeBroad incumbent
Description

Medtronic is a broad medtech incumbent with a substantial GI and surgical portfolio overlapping with Laborie's gastroenterology diagnostics (manometry, pH, paracentesis) and women's health surgical offerings.

TypeDirect peer
Description

Cook Medical is a direct urology peer offering ureteral, stricture, and stone management devices that compete with Laborie's Optilume ureteric and urethral drug-coated balloons in similar hospital call points.

TypeBroad incumbent
Description

Olympus is a global leader in GI endoscopy and therapeutic devices, directly overlapping with Laborie's gastroenterology portfolio (Solar manometry, alpHaONE pH capsule, Renova, GI Supply endoscopy accessories).

TypeDirect peer
Description

CooperSurgical is a women's health medical device company whose ob/gyn and reproductive health portfolio directly overlaps with Laborie's maternal/child health and urogynecology franchises (Eclipse, JADA, Kiwi, Koala).

TypeDirect peer
Description

ConvaTec operates in continence care, ostomy, and advanced wound care — segments that intersect with Laborie's pelvic floor, urinary incontinence, and bowel control franchises served by Macroplastique, Urgent PC, and Eclipse.

TypeBroad incumbent
Description

BD is a broad medtech incumbent with extensive urology, diagnostic, and surgical device franchises, including urodynamics consumables and bladder management products that overlap with Laborie's catheter and urodynamics portfolio.

TypeBroad incumbent
Description

Stryker is a broad medtech incumbent with growing urology, GI, and women's health surgical offerings that compete with Laborie across multiple hospital call points, particularly in surgical and procedural devices.

TypeRegional player
Description

Hologic is a women's health focused medtech company whose diagnostics and surgical franchises (e.g., NovaSure, MyoSure) overlap partially with Laborie's urogynecology and maternal health portfolio, particularly in US hospital systems.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A13 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment8 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Laborie Medical Technologies

Medical Devices (Diagnostic and Therapeutic)laborie.com

Laborie Medical Technologies is a privately held global medical device company that develops and sells diagnostic and therapeutic products for urology, urogynecology, gastroenterology, and maternal and child health, serving hospitals, specialty practices, and health systems in over 50 countries via direct sales and distributors.

What Laborie Medical Technologies does

Laborie Medical Technologies is a privately held, Portsmouth, New Hampshire-headquartered global medical device company that develops, manufactures, and markets diagnostic and therapeutic products across three specialty franchises: Urology & Urogynecology, Gastroenterology, and Maternal & Child Health. Founded in 1967 (per firmographic data) and operating with 501-1,000 employees, the company sells capital equipment systems such as the NXT, Aquarius, and Goby urodynamics platforms, the alpHaONE wireless pH capsule for GERD, and the Solar high-resolution manometry system for GI diagnostics, alongside therapeutic devices including the Optilume drug-coated balloon for BPH and urethral stricture, the Eclipse vaginal insert for fecal incontinence, the JADA vacuum-induced system for postpartum hemorrhage, and the LifeBubble umbilical catheter securement device for NICU use. Revenue is generated through hardware sales of capital equipment and recurring consumables (catheters, sensors, balloons, single-use accessories) sold via a direct enterprise sales force and a global distributor network of 100+ partners across more than 50 countries, supplemented by CME-accredited professional education services delivered through partnerships including the International Continence Society.

Laborie's growth model is built on a programmatic acquisition strategy executed since the 2012 Audax Private Equity investment, with notable transactions including Clinical Innovations (2019, $525M), Cogentix Medical (2018, $239M), Pelvalon (2021), GI Supply (2022), Novonate (2023), Urotronic (2023, ~$600M), and the announced JADA System acquisition from Organon (2025, up to $465M), which together have built a multi-specialty medical device platform with installed bases in over 2,000 U.S. hospitals and 20+ countries for flagship products. The company differentiates through FDA-cleared novel mechanism devices supported by peer-reviewed clinical data (including five-year Optilume efficacy publications and an 86.4% Eclipse success rate at three months), Category 1 CPT reimbursement codes for Optilume BPH, and a global regulatory footprint spanning FDA, CE, and TGA approvals across major geographies.

Go-to-market combines direct enterprise field sales targeting hospital systems and specialist physician practices in urology, urogynecology, gastroenterology, and obstetrics with a tiered regional structure of owned subsidiary offices in the US, Netherlands, UK, France, Germany, Canada, Australia, and China, complemented by extensive distributor relationships across Europe, Asia, the Middle East, Africa, Latin America, and Oceania. Marketing emphasizes clinical evidence and physician education through live courses, webinars, expert corner content, and an e-learning partnership with the International Continence Society, while a Find a Provider directory supports patient access to Laborie-treated providers.

Laborie Medical Technologies firmographics

Firmographics
Name
Laborie Medical Technologies
Legal name
Laborie Medical Technologies Corp.
Website
https://laborie.com
Company type
Private
Founded year
1976
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Laborie Medical Technologies is a privately held global medical device company that develops and sells diagnostic and therapeutic products for urology, urogynecology, gastroenterology, and maternal and child health, serving hospitals, specialty practices, and health systems in over 50 countries via direct sales and distributors.
Ownership category
akta.pro rank

Laborie Medical Technologies industry classification

Industry
Product category
Medical Devices (Diagnostic and Therapeutic)
NAICS
Medical Equipment and Supplies Manufacturing (3391)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Compression Therapy & Lymphedema DME (Garments, Pneumatic Pumps) (HLAHAMAH)
akta.pro secondary industries
Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK), Healthcare & Hospital Linen Laundry (HSAJAEAA)

Keywords

  • Diagnostic medical devices
  • Urodynamics systems
  • Maternal health devices
  • Gastroenterology equipment
  • Urology therapeutics

Where Laborie Medical Technologies is headquartered

Location

Headquarters

HQ city
Portsmouth
HQ country
United States
HQ region
North America

Offices10 records

Markets served

Laborie Medical Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: Sale of diagnostic equipment, therapeutic devices, and capital equipment to hospitals and healthcare providers. Includes urodynamics systems, bladder scanners, drug-coated balloons, and surgical devices.
  2. Consumables and Accessories: Recurring revenue from catheters, sensors, balloons, and other single-use consumables used with diagnostic and treatment systems.
  3. Professional Services and Training: Education services including live courses, online courses, webinars, and training programs for healthcare professionals on product usage and clinical procedures.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/B2B medical device sales - quote-based pricing

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Laborie Medical Technologies product offering

Product offering

Core offering

Laborie Medical Technologies is a global developer, manufacturer, and marketer of proprietary diagnostic and therapeutic medical devices for urology, urogynecology, gastroenterology, and maternal/child health. The company sells capital equipment (urodynamics systems, high-resolution manometry, pH monitoring), therapeutic devices (drug-coated balloons, postpartum hemorrhage control, neuromodulation), and recurring consumables (catheters, sensors, balloons) to hospitals and specialty clinics in 50+ countries.

Product overview

Laborie Medical Technologies operates as a global medical technology company organized around three core specialty areas: Urology & Urogynecology, Gastroenterology, and Maternal & Child Health. The company offers diagnostic and therapeutic medical devices across these domains, with products ranging from advanced urodynamics systems (NXT™, Aquarius®, Goby, Nexam Pro) and drug-coated balloon technologies (Optilume® for BPH and urethral stricture) to gastrointestinal diagnostics (alpHaONE, Solar™ systems, Ohmega™) and maternal-neonatal solutions (JADA® System, LifeBubble®, Kiwi®, Koala®, ABBy™). The portfolio includes both capital equipment systems and disposable consumables, with some products acquired through strategic acquisitions such as Pelvalon (Eclipse™ System), Novonate (LifeBubble®), GI Supply, and Urotronic (Optilume® drug-coated balloon technology).

Differentiator

Problem solved

Functional benefit

Brands

  • Medical Measurement Systems: European headquarters and medical measurement systems subsidiary
  • Clinical Innovations

Products and services

  • NXT™ Family of Urodynamics Systems Advanced urodynamics diagnostic system for evaluating bladder and urethral function in urology and urogynecology patients, used by hospital urology departments and specialty practices.
  • Optilume® BPH Catheter System Drug-coated balloon catheter system with paclitaxel coating for treatment of Benign Prostatic Hyperplasia (BPH), offering a minimally invasive alternative to traditional surgery. FDA-cleared with AMA Category 1 CPT code.
  • Optilume® Urethral Drug Coated Balloon Drug-coated balloon technology for treatment of anterior urethral stricture, mechanically opening the urethra while delivering anti-proliferative paclitaxel medication for durable patency.
  • JADA® System FDA-cleared vacuum-induced device for rapid control of abnormal postpartum uterine bleeding, used in hospital labor and delivery units. Available in 2,000+ US hospitals and 20+ countries.
  • alpHaONE Wireless pH Capsule Reflux Monitoring System Wireless capsule-based pH monitoring system for gastroesophageal reflux disease (GERD) diagnosis, enabling prolonged esophageal pH monitoring without catheter discomfort.
  • Eclipse™ System FDA-cleared vaginal insert for non-surgical treatment of fecal incontinence in women, offering a middle-ground treatment option between conservative care and invasive surgery. Pivotal study showed 86.4% success rate at 3 months.
  • LifeBubble® Umbilical Catheter Securement System NICU medical device for securement of umbilical catheters in neonates, improving safety and outcomes for newborns in intensive care.
  • Aquarius® Family of Urodynamics Systems Comprehensive urodynamics testing platform for assessment of lower urinary tract function, used in urology and urogynecology practices.
  • Goby Family of Wireless Urodynamics Systems Wireless Bluetooth-enabled urodynamics system offering cable-free diagnostic testing for enhanced patient comfort and workflow efficiency.
  • Portascan™ 3D Ultrasound Bladder Scanner 3D ultrasound imaging device for non-invasive bladder volume measurement and assessment.
  • Macroplastique® Minimally invasive injectable bulking agent for treatment of stress urinary incontinence in adult women, primarily due to intrinsic sphincter deficiency.
  • URGENT® PC Percutaneous tibial nerve stimulation (PTNS) system for treatment of overactive bladder and fecal incontinence, providing non-surgical neuromodulation therapy.
  • Solar™ GI High-Resolution Manometry High-resolution manometry system for comprehensive gastrointestinal diagnostic assessment of esophageal and anorectal function.
  • Kiwi® Complete Vacuum Delivery System Vacuum-assisted delivery system for obstetrics, designed to facilitate safe childbirth when intervention is required.
  • ABBy™ Postoperative Panniculus Retractor Surgical retractor device for postoperative panniculus management, supporting wound care and recovery.
  • Koala® Intrauterine Pressure Catheter Intrauterine pressure monitoring catheter for labor management, providing accurate contraction measurement during childbirth.
  • Ohmega™ Impedance/pH monitoring system for comprehensive diagnosis of gastroesophageal reflux disease.
  • PrimeSight® Flexible Cystoscope Flexible video cystoscope with disposable endosheath technology for urological examination, enabling reusable scope functionality with single-use sheath.
  • Spot® Ex Endoscopic Tattoo Endoscopic tattoo marking system for colonic lesion localization during laparoscopic surgery.
  • BabyLance™ Safety Heelstick Safety lancet device designed for safe and effective heel stick blood sampling in neonates.
  • Nexam Pro Urodynamics System Advanced urodynamics diagnostic platform for comprehensive bladder function assessment.
  • Sonesta Chair Range Specialized examination chair designed for urology and gynecology procedures, offering optimized patient positioning and clinician accessibility.
  • ROM Plus® Rupture of Membrane Test Rapid diagnostic test for detection of rupture of fetal membranes during pregnancy assessment.
  • Renova® Products Centesis system for therapeutic fluid drainage procedures in gastroenterology.
  • Solar™ Compact System Compact high-resolution manometry system for gastrointestinal diagnostics, providing detailed pressure mapping of the digestive tract.

Quantifiable outcome

  • 86.4% success rate at 3 months for Eclipse System in pivotal study
  • +2 more outcomes

Companies that use Laborie Medical Technologies

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Laborie Medical Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Laborie Medical Technologies partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • American Urological AssociationcoreGTM or Marketing Partner · 18 May 2026Laborie sponsors the AUA Early-Stage Innovation Nexus Award, a $20,000 grant recognizing exceptional early-stage startups in urology. This partnership supports Laborie's commitment to investing in innovation to advance urologic care.
  • International Continence Society (ICS)coreStrategic or Co-development PartnerLaborie partnered with ICS in developing new Urodynamic modules as part of its eLearning portfolio. The CME-accredited ICS eLearning courses provide comprehensive education from leading experts in Urodynamics.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Laborie Medical Technologies competitors and assessment

Company assessment

Direct peers

  • Coloplast: Coloplast is a direct peer with overlapping portfolios in urology (BPH, urinary continence) and ostomy care, including the Alfapump and BPH device franchises. Both companies serve the same urology specialty customer base with diagnostic and therapeutic solutions.
  • Cook Medical: Cook Medical is a direct urology peer offering ureteral, stricture, and stone management devices that compete with Laborie's Optilume ureteric and urethral drug-coated balloons in similar hospital call points.
  • CooperSurgical: CooperSurgical is a women's health medical device company whose ob/gyn and reproductive health portfolio directly overlaps with Laborie's maternal/child health and urogynecology franchises (Eclipse, JADA, Kiwi, Koala).
  • ConvaTec: ConvaTec operates in continence care, ostomy, and advanced wound care — segments that intersect with Laborie's pelvic floor, urinary incontinence, and bowel control franchises served by Macroplastique, Urgent PC, and Eclipse.

Broad incumbents

  • Boston Scientific: Boston Scientific is a broad medtech incumbent with a significant urology and pelvic health franchise (including its recent Axonics acquisition) that overlaps directly with Laborie's urodynamics, BPH, and incontinence product lines.
  • Medtronic: Medtronic is a broad medtech incumbent with a substantial GI and surgical portfolio overlapping with Laborie's gastroenterology diagnostics (manometry, pH, paracentesis) and women's health surgical offerings.
  • Olympus Corporation: Olympus is a global leader in GI endoscopy and therapeutic devices, directly overlapping with Laborie's gastroenterology portfolio (Solar manometry, alpHaONE pH capsule, Renova, GI Supply endoscopy accessories).
  • Becton, Dickinson and Company (BD): BD is a broad medtech incumbent with extensive urology, diagnostic, and surgical device franchises, including urodynamics consumables and bladder management products that overlap with Laborie's catheter and urodynamics portfolio.
  • Stryker: Stryker is a broad medtech incumbent with growing urology, GI, and women's health surgical offerings that compete with Laborie across multiple hospital call points, particularly in surgical and procedural devices.

Regional players

  • Hologic: Hologic is a women's health focused medtech company whose diagnostics and surgical franchises (e.g., NovaSure, MyoSure) overlap partially with Laborie's urogynecology and maternal health portfolio, particularly in US hospital systems.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Laborie Medical Technologies social profiles

Digital presence

Laborie Medical Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Laborie Medical Technologies leadership team

Management profile

Number of profiles

Profiles9 records

Laborie Medical Technologies subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Laborie Medical Technologies funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Laborie Medical Technologies M&A and investment

M&A and investment

M&A13 records

Investments8 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laborie Medical Technologies

What does Laborie Medical Technologies do?

Laborie Medical Technologies is a global developer, manufacturer, and marketer of proprietary diagnostic and therapeutic medical devices for urology, urogynecology, gastroenterology, and maternal/child health. The company sells capital equipment (urodynamics systems, high-resolution manometry, pH monitoring), therapeutic devices (drug-coated balloons, postpartum hemorrhage control, neuromodulation), and recurring consumables (catheters, sensors, balloons) to hospitals and specialty clinics in 50+ countries.

Is Laborie Medical Technologies a public or private company?

Laborie Medical Technologies is a private company. It is classified as private equity controlled and is currently operating.

When was Laborie Medical Technologies founded?

Laborie Medical Technologies was founded in 1976. It employs 501 to 1,000 people.

Where is Laborie Medical Technologies based?

Laborie Medical Technologies is headquartered in Portsmouth, United States, in the North America region.

How does Laborie Medical Technologies make money?

Three revenue lines are on record. Medical Device Sales are the primary driver. The others are consumables and Accessories and professional Services and Training.

Who are Laborie Medical Technologies's main competitors?

Direct peers on record are Coloplast, Cook Medical, CooperSurgical and ConvaTec. Broad incumbents are Boston Scientific, Medtronic, Olympus Corporation, Becton, Dickinson and Company (BD) and Stryker. Hologic is listed as a regional player.

Does Laborie Medical Technologies have an API?

No public API is recorded for Laborie Medical Technologies.

What industry is Laborie Medical Technologies in?

Laborie Medical Technologies's product category is Medical Devices (Diagnostic and Therapeutic). Its primary akta.pro industry code is HLAHAMAH, Compression Therapy & Lymphedema DME (Garments, Pneumatic Pumps), with a secondary code of HLAHAGAK, Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers). Its NAICS code is 3391 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
news.cision.comMichael “Mike” Frazzette, former President and Chief Executive Officer of Laborie Medical TechnologiesMichael Frazzette has stepped down from his role as President and Chief Executive Officer of Laborie Medical Technologies. The announcement is part of a broader strategic update by Wellspect HealthCare, which also established a Strategic Advisory Board including Mr. Frazzette. This transition marks a leadership change within the medical device subsidiary.openPR.comAnalysis of Key Market Segments Driving the Ureteroscope MarketThe Business Research Company published a market analysis projecting the global ureteroscope market to reach $1.53 billion by 2030, growing at a 5.6% CAGR, driven by increasing kidney disease prevalence, demand for disposable endoscopic tools, and advancements in digital imaging. In October 2023, Laborie Medical Technologies acquired Urotronic for approximately $600 million to expand its urology portfolio with Urotronic's Optilume drug-coated balloon technology. Boston Scientific received FDA approval in February 2023 for its LithoVue Elite single-use digital flexible ureteroscope system featuring real-time intrarenal pressure monitoring.openPR.comGlobal Factors Influencing the Rapid Evolution of the Urology Devices MarketThe urology devices market is projected to reach $56.39 billion by 2030, growing at a 7.0% CAGR, driven by investments in robotic surgery platforms, minimally invasive procedures, and advanced diagnostic technologies. In October 2023, Laborie Medical Technologies acquired Urotronic, Inc. to expand its interventional urology portfolio with the Optilume drug-coated balloon technology. In September 2024, Olympus Corporation launched its CH-S700-08-LB 4K camera head for urological and gynecological endoscopy procedures.openPR.comGlobal Factors Influencing the Rapid Evolution of the Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment MarketThe global benign prostatic hyperplasia (BPH) treatment devices and equipment market is projected to grow from $1.29 billion in 2024 to $1.86 billion by 2030, reflecting a compound annual growth rate of 6.9%, driven by an aging male population and increasing preference for minimally invasive procedures. In October 2023, US-based Laborie Medical Technologies Corp. acquired Urotronic Inc. to incorporate its Optilume drug-coated balloon technology, strengthening Laborie's therapeutic urology portfolio and global reach. In February 2025, Japan-based Olympus Corporation announced expanded availability of its iTind temporarily implantable device across major Asia-Pacific markets including Thailand, Australia, Hong Kong, Singapore, India, with a planned launch in Korea.PR NewswireLaborie Acquires the JADA® System for Rapid Postpartum Hemorrhage Control, Expanding Obstetrics PortfolioLaborie Medical Technologies announced the closing of its acquisition of the JADA® System, an FDA-cleared medical device for the rapid control and treatment of abnormal postpartum uterine bleeding. The JADA System, which has helped over 136,000 mothers in more than 20 countries, addresses postpartum hemorrhage—the leading cause of maternal mortality worldwide, accounting for more than 20% of all maternal deaths. More than 90 new colleagues in commercial roles will join Laborie as part of the transaction, strengthening the company's obstetrics portfolio that spans antepartum, intrapartum, postpartum, neonatal, and surgical care.LaborieLaborie Acquires the JADA® System for Rapid PPH ControlLaborie has acquired the JADA® System, which is used for rapid postpartum hemorrhage (PPH) control.Market ScoopVaginal Inserts MarketThe global vaginal inserts market is projected to grow from US$ 1.6 billion in 2024 to US$ 2.7 billion by 2034, representing a compound annual growth rate of 5.3% during the forecast period. In November 2025, Laborie Medical Technologies agreed to acquire the JADA System from Organon for US$ 465 million, a specialized vacuum-induced vaginal insert used for managing abnormal postpartum uterine bleeding, consolidating Laborie's position in the acute maternal health market. The market is driven by rising prevalence of gynecological conditions, increasing demand for non-oral contraceptive options, and expanding FDA approvals for generic vaginal inserts.news.cision.comPatricia Industries’ subsidiary Laborie to acquire the JADA SystemPatricia Industries' subsidiary Laborie has entered into an agreement to acquire the JADA® System from Organon for USD 440m, with a potential additional payment of up to USD 25m contingent on 2026 revenue targets, expected to close in Q1 2026 subject to regulatory approval. The JADA® System is a medical device for treating postpartum uterine bleeding that generated USD 67m in revenues for the 12 months ending June 30, 2025, and approximately 100 employees are expected to join Laborie as part of the transaction. The acquisition expands Laborie's obstetrics business unit and aligns with Patricia Industries' strategy of building platform companies through strategic add-on acquisitions.TradingViewPatricia Industries' subsidiary Laborie to acquire the JADA SystemLaborie, a subsidiary of Patricia Industries (owned by Investor AB), has agreed to acquire the JADA® System from Organon for USD 440 million, with an additional potential payment of up to USD 25 million tied to 2026 revenue targets, bringing total potential value to USD 465 million. The JADA® System, a medical device for treating postpartum hemorrhage, generated revenues of USD 67 million for the 12 months ending June 30, 2025, and will expand Laborie's obstetrics business unit. Approximately 100 employees, primarily in commercial roles, will join Laborie upon closing, which is expected in Q1 2026 pending regulatory approval.MorningstarLaborie to Buy Specialist Medical Device For Up To $465 Million From OrganonMedical device developer Laborie has agreed to acquire the Jada System from Organon for up to $465 million, consisting of $440 million at closing plus up to $25 million contingent on 2026 revenue targets. The Jada System is used to treat abnormal bleeding after childbirth and is currently available in more than 20 countries globally. Laborie is owned by Patricia Industries, a subsidiary of Swedish investment and holding company Investor AB.